AI assistant
Oxurion NV — Major Shareholding Notification 2025
Jul 14, 2025
3987_mrq_2025-07-14_7026e1e1-a33b-4139-a06e-5a48e14ad0c1.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Leuven, BELGIUM – July 14, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows:
Oxurion received a transparency notification on July 9, 2025, from Atlas Special Opportunities II, LLC indicating that as of July 3, 2025, it held 3,931,718 shares of the then outstanding 12,428,021 shares, and therefore crossed above the threshold (30%) by virtue of the purchase of voting securities.
Oxurion received a transparency notification on July 9, 2025, from Atlas Special Opportunities II, LLC indicating that as of July 8, 2025, it held 3,524,934 shares of the then outstanding 12,428,021 shares, and therefore crossed under the threshold (30%) by virtue of the selling of voting securities.
About Oxurion
Oxurion NV (Euronext Brussels: OXUR) is a biopharmaceutical group in transition, combining therapeutic innovation with technologies applied to clinical research. Through its rapidly expanding technology division, Oxurion is building integrated expertise around clinical data, with the ambition to accelerate, secure, and transform the processes involved in developing new treatments. The Group's headquarters are based in Leuven, Belgium. More information is available at www.oxurion.com.
Important information about forward-looking statements
Certain statements in this press release may be considered "forward-looking". Such forward-looking statements are based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forwardlooking statement is contained in the Company's Annual Report. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of Oxurion in any jurisdiction. No securities of Oxurion may be offered or sold within the United States without registration under the U.S. Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. state securities laws.
For further information please contact:
Oxurion NV Pascal Ghoson Chief Executive Officer [email protected]
________
- Article 14, first paragraph, of the Law of 2 May 2007 on disclosure of major holdings.
ANNEX 1
| FSMA FINANCIAL SERVICES AND MARKETS AUTHORITY |
Transparency notification Form TR-1 BE PART I |
|
|---|---|---|
| 1) Status of the notification. | ||
| Final | ||
| 2) Issuer | ||
| OXURION Name |
||
| Identification number 0881-620-924 | ||
| 3) Reason for the notification | ||
| Acquisition or disposal of voting securities or voting rights | ||
| 4) Notification by | ||
| A person that notifies alone | ||
| 5) Persons subject to the notification requirement | ||
| Name | Address (for legal entitles) | |
| Atlas Special Opportunities II LLC | 2500 Westchester Avenue, Suite 401, Purchase, NY 10577 | |
| 6) Persons that dispose of voting rights (only to be filled in it art. 7 of the Law applies) | ||
| Name | Address (for legal entitles) | |
| Please continue entering the information in part it concerning the persons referred to In Sections 5 and 6 |
Part II | |
| 7) Date on which the threshold is crossed | ||
| 03/07/2025 (DD/MM/YYYY) | ||
| 8) Threshold that is crossed (In %) | ||
| 30 | ||
| If the holding has fallen below the lowest threehold, you have the option of not entering any numbers in Section 10 | ||
| 9) Denominator | ||
| 12,428,021 | ||
| Please enter the denominator before filling in the data | ||
| 10) Notified details | ||
| A) Voting rights | Previous notification | After the transaction | |||
|---|---|---|---|---|---|
| # of voling rights | # of voting rights | % of voting rights | |||
| Holders of voting rights | Linked to securities | Not linked to the securities |
Linked to securities | Not linked to the securities |
|
| Atlas Special Opportunities II LLC | 26,211 | 3,931,718 | |||
| TOTAL | 3,931,718 | 0 | 31.64% | 0.00% |
| B) Equivalent financial Instruments | After the transaction | ||||||
|---|---|---|---|---|---|---|---|
| Holders of equivalent financial instruments |
Type of financial Instrument | Expiration date | Exercise period or date |
# of voting rights that may be acquired if the Instrument Is exercised |
% of voting rights | Settlement | |
| + | |||||||
| TOTAL | 0 | 0.00% |
The zorals will be updated once you have cilcked on «CALCULATE>
| TOTAL (A & B) | # of voting rights % of voting rights | ||
|---|---|---|---|
| CALCULATE | 3,931,718 | 31.64% |
11) Full chain of controlled undertakings through which the holding is effectively held, it applicable
| Atlas Special Opportunities II LLC is not a controlled entity. | |
|---|---|
| 12) In case of proxy votinq for only one GM | |
| will cease to hold / voting rights as of Holder will hold again |
(DD/MM/YYYY) |
| 13) Additional information | |
| On 27 June 2025 (with settlement date on 0 July 2025), Mias Special Open N1, as a result of which Its starebrith decessed on 211 share ( 0.31%, denominator = 8,496,303). On 3 July 2025 (with editernent date on 3 July 2025), Allas Special 3,531,116 stares in Orudion NJ, as a result third its stareholding increased b 3,93,718 stares (- 31.64%, denominator = 12,428,021). |
|
| Done at New York | ||||
|---|---|---|---|---|
| On | 08/07/2025 (DDIMMYYYY) | |||
| Name & capacity Patrick Vance, Proxyholder | -Signed by: Patrick Varree Slanature |
For security reasons, the unsigned form in xisx format should
be transmitted to [email protected]. You can do this manually
OR if you have MS Outlook at your disposal via the
In addition, a signed copy in EDE format should also be
transmitted.
ANNEX 2
| FSMA | FINANCIAL SERVICES AND MARKETS AUTHORITY |
Transparency notification Form TR-1 BE PART I |
||||
|---|---|---|---|---|---|---|
| 1) Status of the notification | ||||||
| Final | ||||||
| 2) Issuer | ||||||
| Identification number 0881-620-924 | Name OXURION | |||||
| 3) Reason for the notification | ||||||
| Acquisition or disposal of voting securities or voting rights | ||||||
| 4) Notification by | ||||||
| A person that notifies alone | ||||||
| 5) Persons subject to the notification requirement | ||||||
| Name | Address (for legal entifies) | |||||
| Atlas Special Opportunities II LLC | 2500 Westchester Avenue, Suite 401, Purchase, NY 10577 | |||||
| 6) Persons that dispose of voting rights (only to be filled in if art. 7 of the Law applies) | ||||||
| Name | Address (for legal entifies) | |||||
| Please continue entering the information in part if concerning the persons referred to In Sections 5 and 6 |
Part II | |||||
| 7) Date on which the threshold is crossed | ||||||
| 08/07/2025 (DD/MM/YYYY) | ||||||
| 8) Threshold that is crossed (in %) | ||||||
| 30 | ||||||
| If the holding has fallen below the lowest threehold, you have the option of not entering any numbers in Section 10 | ||||||
| 9) Denominator | ||||||
| 12,428,021 | ||||||
| Please enter the denominator before filling in the data | ||||||
| 10) Notified details | ||||||
| A) Voling rights | Previous notification | After the transaction | ||||
| # of voting rights | # of voting rights Not linked to the |
% of voting rights Not linked to the |
| 11 1 COLUM 11/01/20 | Control Concession | ||||||
|---|---|---|---|---|---|---|---|
| # of voting rights | # of voting rights | % of voting rights | |||||
| Holders of voting rights | Linked to securities | Not linked to the securities |
Linked to securities | Not linked to the securities |
|||
| Atlas Special Opportunities II LLC | 3.931.718 | 3.524.934 | |||||
| TOTAL | 3,524,934 | 0 | 28.36% | 0.00% | |||
+
illy Start with "groupe" of holders. Add subtotals with the person or legal entity.
For groupe, start with the uitmate controling natural person or legal entity.
The
| TOTAL (A & B) | # of voting rights % of voting rights | ||||||
|---|---|---|---|---|---|---|---|
| The torals will be updated once you have cilicked on «CALCULATE> 48 |
|||||||
| TOTAL | 0 | 0.00% | |||||
| + | |||||||
| Holders of equivalent financial instruments |
Type of financial Instrument | Expiration diate | Exercise period or diste |
# of voting rights that may be acquired if the Instrument Is exercised |
% of voting rights | Settlement | |
| B) Equivalent financial Instruments | After the transaction |
11) Full chain of controlled undertakings through which the holding is effectively held, it applicable

3,524,934
CALCULATE
28.36%
12) In case of proxy voting for only one GM

13) Additional information
On 3.4% (area de 13.4%) - 120%, Mas Special Opodnities il LC aquira 3,0,778 areald drim it sanchdronim is aneridade prosesed a,30,17 latare (
1,83%, enning = 1,280,00)

For security reasons, the unsigned form in xlsx format should
be transmitted to [email protected]. You can do this manually
OR it you have MS Outlook at your disposal via th
In addition, a signed copy in EDE format should also be
transmitted.